News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,917 Results
Type
Article (9796)
Company Profile (72)
Press Release (159049)
Section
Business (54703)
Career Advice (146)
Deals (8939)
Drug Delivery (17)
Drug Development (26849)
Employer Resources (23)
FDA (3710)
Job Trends (4379)
News (91590)
Policy (5706)
Tag
Academia (522)
Alliances (15074)
Alzheimer's disease (219)
Antibody-drug conjugate (ADC) (84)
Approvals (3738)
Artificial intelligence (92)
Bankruptcy (83)
Best Places to Work (3851)
Biotechnology (62)
Bladder cancer (47)
Breast cancer (172)
Cancer (1315)
Career advice (127)
CAR-T (71)
Cell therapy (162)
Clinical research (22065)
Collaboration (315)
Compensation (77)
COVID-19 (456)
C-suite (84)
Data (676)
Diagnostics (1769)
Drug discovery (47)
Earnings (16347)
Events (27271)
Executive appointments (261)
FDA (4003)
Funding (380)
Gene therapy (58)
GLP-1 (144)
Government (569)
Healthcare (4997)
Infectious disease (481)
IPO (4323)
Job creations (745)
Job search strategy (119)
Layoffs (142)
Legal (716)
Lung cancer (221)
Lymphoma (67)
Manufacturing (54)
Medical device (1993)
Medtech (1995)
Mergers & acquisitions (4739)
Metabolic disorders (101)
Neuroscience (299)
NextGen: Class of 2025 (1674)
Non-profit (749)
Northern California (808)
Obesity (61)
Opinion (69)
Ovarian cancer (48)
Pancreatic cancer (45)
People (19262)
Phase I (8170)
Phase II (9427)
Phase III (6980)
Pipeline (307)
Postmarket research (548)
Preclinical (2737)
Prostate cancer (61)
Radiopharmaceuticals (167)
Rare diseases (80)
Real estate (1221)
Regulatory (4896)
Research institute (781)
Series A (93)
Series B (59)
Southern California (628)
Startups (2483)
United States (5756)
Vaccines (127)
Date
Today (50)
Last 7 days (216)
Last 30 days (852)
Last 365 days (11412)
2025 (1799)
2024 (11669)
2023 (12962)
2022 (17202)
2021 (16763)
2020 (14545)
2019 (11993)
2018 (9139)
2017 (9449)
2016 (8255)
2015 (9297)
2014 (6326)
2013 (4607)
2012 (4973)
2011 (5095)
2010 (4948)
Location
Africa (131)
Asia (13605)
Australia (1759)
California (1685)
Canada (723)
China (226)
Colorado (50)
Connecticut (71)
Delaware (87)
Europe (25515)
Florida (183)
Illinois (159)
Indiana (57)
Japan (69)
Maryland (208)
Massachusetts (1348)
Minnesota (72)
New Jersey (412)
New York (394)
North Carolina (194)
Northern California (808)
Ohio (54)
Pennsylvania (244)
South America (189)
Southern California (628)
Texas (262)
Utah (47)
Washington State (151)
168,917 Results for "oncology venture".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES
February 18, 2025
·
2 min read
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Startups
BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture
With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.
August 22, 2024
·
2 min read
·
Tristan Manalac
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix Acquisition Corp. II worth $450 million in proceeds.
February 28, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Texas Children’s Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
February 19, 2025
·
4 min read
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.
June 14, 2024
·
2 min read
·
Tyler Patchen
Press Releases
C the Signs Announces Investment From Khosla Ventures to Advance AI-Powered Early Cancer Detection
January 31, 2025
·
3 min read
Press Releases
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma
December 12, 2024
·
5 min read
Press Releases
Salience Labs Closed Series A Round Led by Applied Ventures and ICM HPQC Fund
February 7, 2025
·
4 min read
Press Releases
Happen Ventures Helps Honest Medical Divert Surplus Medical Supplies
January 15, 2025
·
2 min read
1 of 16,892
Next
